Tuesday - September 2, 2025
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
July 28, 2025
SAN ANTONIO, Texas, July 28 [Category: BizConsulting] -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services, posted the following news release:

* * *

Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis

*

Abstract

Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products